Galvanize PROPEL Registry study - An observational, retrospective and prospective, single-arm, consecutive enrollment, multi-center registry. This registry will be conducted at up to 25 sites in the US.
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Galvanize Therapeutic Inc.
Start Date
May 8, 2025
End Date
April 30, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Galvanize Therapeutic Inc.
Start Date
May 8, 2025
End Date
April 30, 2030